Table 4 Main adverse outcomes among fetuses and infants vertically ZIKV-exposed from the cohort of Goiânia, Goiás, Brazil, 2017-2019.
Outcomes | ZIKV-exposed group n=44 | % (95% CI)a |
|---|---|---|
Primary outcomes | ||
Microcephaly within one year of age | 3/43 | 7.0% (1.5–19.1) |
Congenital Zika Syndrome | 5/44 | 11.4% (4.3–23.4) |
Secondary outcomes | ||
Microcephaly by prenatal ultrasound or abnormal brain imaging | 2/40 | 5.0% (0.9–15.5) |
Microcephaly at birth | 4/44 | 9.1% (3.7–17.9) |
Ophthalmological anomalies (retinal and/or optic nerve) | 24/44 | 54.5% (39.8-68.7) |
